For appropriate patients faced with relapsed/refractory multiple myeloma

Forge ahead

with a bold approach

Target BCMA for RRMM

BLENREP is the first and only BCMA-targeted ADC monotherapy. So you can offer your RRMM patients a different option.1

ADC=antibody-drug conjugate; BCMA=B-cell maturation antigen; RRMM=relapsed or refractory multiple myeloma.